HKMPY News and Press, Hikma Pharmaceuticals Plc ADR

2024-03-20 04:02:20 ET More on Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC (HKMPF) Q4 2023 Earnings Call Transcript Historical earnings data for Hikma Pharmaceuticals PLC Dividend scorecard for Hikma Pharmaceuticals PLC Financial information for Hikma...

2024-02-22 12:33:03 ET Hikma Pharmaceuticals PLC (HKMPF) Q4 2023 Earnings Conference Call February 22, 2024, 07:00 AM ET Company Participants Susan Ringdal - EVP, Strategic Planning and Global Affairs Riad Mishlawi - CEO Khalid Nabilsi - CFO Bill Larkins - He...

2024-01-09 03:48:00 ET Summary In terms of dividend yield, there was a clear gap between the portfolio’s yield and the All-Share's yield throughout 2023 and by the end of the year, the portfolio had a dividend yield of exactly 5% compared to the FTSE All-Share’s yield of...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Hikma Pharmaceuticals PLC (“Hikma”), a multinational pharmaceutical company, today announced an agreement to promote Guardant Health’s portfolio of liquid and tissue biopsy tests for cancer screenin...

2023-12-01 13:40:47 ET More on Amarin, Amneal, etc. Amneal Pharmaceuticals, Inc. (AMRX) Q3 2023 Earnings Call Transcript Amneal Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation Amarin Corporation plc (AMRN) Q3 2023 Earnings Call Transcript ...

Rakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North Africa PR Newswire SAN DIEGO , Aug. 10, 2023 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company devel...

2023-08-04 12:18:02 ET Hikma Pharmaceuticals PLC (HKMPF) Q2 2023 Earnings Conference Call August 03, 2023 04:30 AM ET Company Participants Susan Ringdal - Executive Vice President, Strategic Planning & Global Affairs Said Darwazah - Chief Executive Officer Ri...

2023-05-23 06:21:26 ET Shanghai Junshi Biosciences ( OTCPK:SHJBF ) said China's National Medical Products Administration (NMPA) accepted an application seeking expanded approval of toripalimab, in combination with albumin-bound paclitaxel, to treat PD-L1 positive (CPS ≥ 1) untrea...

2023-05-06 05:25:00 ET Summary Hikma Pharmaceuticals is a FTSE 250 generic drug manufacturer that was founded in the Middle East in 1978. The company has many attractive features, including a long track record of progressive dividend growth, so I added it to my dividend portfolio ...

2023-03-29 06:05:32 ET Shanghai Junshi Biosciences ( OTCPK:SHJBF ) is collaborating with Rxilient Biotech to develop and sell cancer drug toripalimab through a joint venture, Excellmab, in nine Southeast Asian nations. Under the agreement, Rxilient will subscribe ...